ORDER A TEST Log In Contact Us
Back TO events
September 25 — 26, 2024 BOSTON, MA

Plenary Session

RAS-Targeted Drug Development Summit 2024

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the 6th Annual RAS-Targeted Drug Development Summit and present on Tempus’ strategic solutions for RAS development from early discovery through commercialization.

Schedule a meeting with us
Plenary Session
September 25, 2024
live session
Time
10:15am-10:45am ET

Location
Revere Hotel Boston Common
200 Stuart Street
Boston, MA 02116
Presenter
Josh SK Bell, PhD
Sr. Director of Data Solutions (Tempus)

Beyond G12: Comprehensive RAS Biomarker Strategy and Clinical Development

KRAS G12C is only the first druggable alteration in RAS genes. Tempus’ multimodal, de-identified data and certain assays can help identify a broad set of biomarkers in responsive patients including KRAS, HRAS, and NRAS amplifications, over-expression, and mutations, in addition to tumor immune microenvironment factors that may influence response to RAS neoantigen vaccines, revealing critical insights for targeted therapy development. Gain perspective on the significance of RAS alteration patterns to outcomes to standard of care and their potential to guide precision oncology, enhancing treatment efficacy and patient outcomes.

Read more

Schedule a meeting with us

We'll be in touch shortly.